Clinical Trials Sponsored by Kelindi

Total 439 results

Weprom
Kelindi

Recruiting

Assessment of the Feasibility of Using a Smartphone Application for the Prevention and Screening of Burnout (BURNOUT ADVICE) (BURNOUT ADVICE)

Burnout, Professional

France
Weprom
Kelindi

Recruiting

A Smartphone Application for Screening of Developmental Disorders in Children

Development, Child

France
Weprom
Kelindi

Completed

Early Detection Neurodevelopmental Disorders of Children and Prevention of Postnatal Depression by Mobile Health App

Development, Child | Postnatal Depression

France
Weprom
Kelindi

Completed

Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application (SourceCOVID)

Covid19

France
Weprom
Kelindi

Completed

Optimization of Mother-child Dyad Follow-up by a Multidomain Application: Real-world Cross Sectional Study (MALO_2)

Post Partum Depression | Child Development Disorder

France
Melinda Telli

Terminated

Vitamin D and Breast Cancer: Does Weight Make a Difference?

Breast Cancer

United States
Melinda Seering

Not yet recruiting

Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties

Anesthesia | Post Operative Pain | Shoulder Osteoarthritis | Nerve Block

United States
Melinda Seering

Completed

Comparison of Pre-op and Post-op Pectoralis Nerve Block

Breast Cancer | Postoperative Pain | Anesthesia | Nerve Block

United States
Bill & Melinda Gates Medical Research Institute
Bill and Melinda Gates Foundation; Wellcome Trust

Recruiting

Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults

Tuberculosis

Indonesia, Kenya, Malawi, Mozambique, South Africa, Vietnam, Zambia
Melinda Seering

Completed

Analgesia Duration of Dexamethasone, Buprenorphine, or Clonidine With Ropivacaine for Interscalene Nerve Block

Anesthesia, Local

United States
Weprom
Centre National de la Recherche Scientifique, France; Kelindi; Hospital of Tours

Completed

Study Evaluating the Olfactory Recovery of Anosmia Post COVID-19 by Olfactory Rehabilitation Assisted by Web-application (COVIDANOSMIA)

Covid19

France
Bill & Melinda Gates Medical Research Institute

Recruiting

Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults

Malaria

United States
Bill & Melinda Gates Medical Research Institute

Active, not recruiting

Impact of Bi-26 Supplementation on Weight Gain in Underweight Infants

Underweight | Paediatrics

Pakistan
Jhpiego
Bill and Melinda Gates Foundation

Completed

Effects of a Health Workforce Capacity Building and Quality Improvement Intervention in Kinshasa

Infant Death | Maternal Death | Stillbirth

Congo, The Democratic Republic of the
Novavax
Bill and Melinda Gates Foundation

Completed

A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization

Respiratory Syncytial Virus Infections

United States, Argentina, Australia, Bangladesh, Chile, Mexico, New Zealand, Philippines, South Africa, Spain, United Kingdom
IDRI
Bill and Melinda Gates Foundation

Completed

Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers

Visceral Leishmaniasis

United States
IDRI
Bill and Melinda Gates Foundation

Completed

Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India

Visceral Leishmaniasis | Post-kala-azar Dermal Leishmaniasis

India
PATH
Bill and Melinda Gates Foundation

Withdrawn

Efficacy of iOWH032 in Dehydrating Cholera (POC)

Secretory Diarrhea

Bangladesh
Bill & Melinda Gates Medical Research Institute

Active, not recruiting

Epidemiologic Study to Assess the IGRA Positivity in Populations With a High TB Burden

Tuberculosis, Pulmonary

South Africa, Bangladesh, Brazil, India, Indonesia, Mozambique, Zambia, Congo, The Democratic Republic of the, Gambia, Kenya, Peru, Philippines, Uganda, Vietnam
Bill & Melinda Gates Medical Research Institute

Active, not recruiting

Bacille Calmette Guerin (BCG) Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection

Tuberculosis

South Africa
PATH
Bill and Melinda Gates Foundation

Completed

Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination

Virus Diseases | Hepatitis B
IDRI
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis

Leishmaniasis, Mucocutaneous

Peru
IDRI
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis

Leishmaniasis, Cutaneous

Brazil
IDRI
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite

Cutaneous Leishmaniasis

Colombia
Bill & Melinda Gates Medical Research Institute

Completed

Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis

Pulmonary Tuberculosis

South Africa
Novavax
Bill and Melinda Gates Foundation

Completed

A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults

COVID-19 | SARS-CoV-2 Infection

South Africa
Bill & Melinda Gates Medical Research Institute

Terminated

A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19)

COVID-19

United States, United Kingdom
Jhpiego
Bill and Melinda Gates Foundation

Completed

Accelerating Newborn Survival in Ghana Through a Low-dose, High-frequency Health Worker Training Approach

Stillbirth | Neonatal Death
IDRI
Bill and Melinda Gates Foundation

Completed

Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite

Cutaneous Leishmaniasis

Colombia
Fidec Corporation
Bill and Melinda Gates Foundation

Active, not recruiting

A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2

Poliomyelitis

Bangladesh
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate the Safety and Immunogenicity of Novel Oral Polio Vaccine

Poliomyelitis

Panama
Stanford University
Bill and Melinda Gates Foundation

Completed

Team-Based Goals and Incentives for Community-Based Health Workers to Promote Maternal and Child Health in Bihar, India

Healthy
Certara
Bill and Melinda Gates Foundation; Parexel

Completed

International Registry of Healthcare Workers Exposed to COVID-19 Patients (UNITY Global) (UNITY Global)

Covid19 | SARS-CoV Infection

Pakistan
Makerere University
Bill and Melinda Gates Foundation

Active, not recruiting

Effect of Digital Payment to Campaign Health Workers on Vaccination Coverage

Polio

Uganda
Fidec Corporation
Bill and Melinda Gates Foundation

Withdrawn

A Study to Evaluate Immunogenicity of Various Schedules of Inactivated Polio Vaccine

Poliomyelitis
FHI 360
Bill and Melinda Gates Foundation

Completed

Contraceptive Effectiveness of Sino-implant (II) in China

Contraception

China
PATH
Bill and Melinda Gates Foundation; UNITAID

Recruiting

TIMCIs: A Hybrid Type 2 Study of Next-generation Pulse Oximeters

Focus of Study: Accurate Clinical Measurement and Diagnosis

Kenya
Tufts University
Bill and Melinda Gates Foundation

Recruiting

Safe and Effective Delivery of Supplemental Iron to Healthy Volunteers

Iron

United States
Yale University
Bill and Melinda Gates Foundation

Completed

Topical Antibacterial Agents for Prevention of COVID-19

COVID-19 | SARS-CoV2 Infection

United States
Stanford University
Bill and Melinda Gates Foundation

Completed

Use of Mobile Technology by Community-Based Health Workers to Promote Maternal and Child Health in Bihar, India (ICT-CCS)

Child | Pregnancy | Infant | Nutrition | Health
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

Study to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in Infants

Poliomyelitis

Dominican Republic
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate the Safety and Immunogenicity of Oral Polio Vaccine Type 2 in Infants and Children (M2-ABMG)

Adverse Event Following Immunisation
VaxInnate Corporation
Bill and Melinda Gates Foundation

Completed

Phase I Safety and Immunogenicity Study of VAX102 [Flagellin.HuM2e] Influenza Vaccine in Healthy Adults

Influenza Infection

United States
Makerere University
Bill and Melinda Gates Foundation

Completed

School Based Malaria Control in Ugandan Schoolchildren (SBMC)

Malaria

Uganda
El Kendi Pharmaceuticals Manufacturing Company

Completed

Evaluate Efficacy of the Association Nimotuzumab(HR3) /Cisplatin-Vinorelbine on Patients With Cervical Carcinom (CIMAHOPE)

Cervical Cancer

Algeria
Population Council
Bill and Melinda Gates Foundation

Recruiting

Pilot Study on Engaging Family Physicians in Family Planning in Pakistan (FPFP)

Contraception | Contraceptive Usage

Pakistan
FHI 360
Bill and Melinda Gates Foundation

Recruiting

Casea S Contraceptive Implants (Casea S) Trial

Contraception

Dominican Republic
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV

Poliomyelitis

Dominican Republic, Panama
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age (T2-ABMG)

Poliomyelitis
Melinda Telli
Pfizer; BioMarin Pharmaceutical

Completed

Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors

Advanced Breast Cancer | HER2/Neu Negative | Triple-Negative Breast Cancer

United States

Clinical Trials Sponsored by Kelindi

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations